We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · June 15, 2017

TNF-α Inhibitors Are Effective in Cutaneous Sarcoidosis, but Infections Are Common

JAMA Dermatology


Additional Info

JAMA Dermatology
Efficacy and Tolerance of Anti-Tumor Necrosis Factor-α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases
JAMA Dermatol 2017 May 31;[EPub Ahead of Print], V Heidelberger, S Ingen-Housz-Oro, A Marquet, M Mahevas, D Bessis, L Bouillet, F Caux, C Chapelon-Abric, S Debarbieux, E Delaporte, AB Duval-Modeste, O Fain, P Joly, S Marchand-Adam, JB Monfort, N Noël, T Passeron, M Ruivard, F Sarrot-Reynauld, D Verrot, D Bouvry, L Fardet, O Chosidow, P Sève, D Valeyre

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading